Literature DB >> 27114488

Including males in Canadian human papillomavirus vaccination programs: a policy analysis.

Gilla K Shapiro1, Samara Perez2, Zeev Rosberger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27114488      PMCID： PMC5008935          DOI： 10.1503/cmaj.150451

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  40 in total

1.  Provinces weighing HPV vaccination of boys.

Authors:  Laura Eggertson
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

2.  Do you approve of spending $300 million on HPV vaccination?: yes.

Authors:  Marc Steben
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

Review 3.  Approved but non-funded vaccines: accessing individual protection.

Authors:  David W Scheifele; Brian J Ward; Scott A Halperin; Shelly A McNeil; Natasha S Crowcroft; Gordean Bjornson
Journal:  Vaccine       Date:  2013-12-25       Impact factor: 3.641

4.  HPV vaccination crisis in Japan.

Authors:  Sharon J B Hanley; Eiji Yoshioka; Yoshiya Ito; Reiko Kishi
Journal:  Lancet       Date:  2015-06-27       Impact factor: 79.321

5.  Perspective: Vaccinate boys too.

Authors:  Margaret Stanley
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

6.  The Feminization of HPV: Reversing Gender Biases in US Human Papillomavirus Vaccine Policy.

Authors:  Ellen M Daley; Cheryl A Vamos; Gregory D Zimet; Zeev Rosberger; Erika L Thompson; Laura Merrell
Journal:  Am J Public Health       Date:  2016-06       Impact factor: 9.308

7.  A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.

Authors:  Donna M Graham; Wanrudee Isaranuwatchai; Steven Habbous; Claire de Oliveira; Geoffrey Liu; Lillian L Siu; Jeffrey S Hoch
Journal:  Cancer       Date:  2015-04-13       Impact factor: 6.860

Review 8.  Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Authors:  Susanne Hartwig; Stina Syrjänen; Géraldine Dominiak-Felden; Maria Brotons; Xavier Castellsagué
Journal:  BMC Cancer       Date:  2012-01-20       Impact factor: 4.430

9.  Prevalence of anal human papillomavirus infection and cytologic abnormalities among HIV-infected and HIV-uninfected men who have sex with men.

Authors:  Alessandra Latini; Maria Gabriella Dona; Livia Ronchetti; Amalia Giglio; Domenico Moretto; Manuela Colafigli; Valentina Laquintana; Mirko Frasca; Mauro Zaccarelli; Andrea Antinori; Antonio Cristaudo; Massimo Giuliani
Journal:  J Int AIDS Soc       Date:  2014-11-02       Impact factor: 5.396

Review 10.  Towards the eradication of HPV infection through universal specific vaccination.

Authors:  Piergiorgio Crosignani; Antonella De Stefani; Gaetano Maria Fara; Andrea M Isidori; Andrea Lenzi; Carlo Antonio Liverani; Alberto Lombardi; Francesco Saverio Mennini; Giorgio Palu'; Sergio Pecorelli; Andrea P Peracino; Carlo Signorelli; Gian Vincenzo Zuccotti
Journal:  BMC Public Health       Date:  2013-07-11       Impact factor: 3.295
View more
  14 in total

1.  Supporting the call for a gender-neutral human papillomavirus vaccination in Canada.

Authors:  Cyra Patel; Kristine Macartney
Journal:  CMAJ       Date:  2017-01-23       Impact factor: 8.262

2.  The authors respond to "Supporting the call for a gender-neutral human papillomavirus vaccination in Canada".

Authors:  Gilla K Shapiro; Samara Perez; Zeev Rosberger
Journal:  CMAJ       Date:  2017-01-23       Impact factor: 8.262

3.  Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia.

Authors:  Li Ping Wong; Pooi-Fong Wong; Megat Mohamad Amirul Amzar Megat Hashim; Liyuan Han; Yulan Lin; Zhijian Hu; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

4.  Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study.

Authors:  Samara Perez; Ovidiu Tatar; Gilla K Shapiro; Eve Dubé; Gina Ogilvie; Juliet Guichon; Vladimir Gilca; Zeev Rosberger
Journal:  BMC Public Health       Date:  2016-12-05       Impact factor: 3.295

5.  HPV vaccination in male physicians: A survey of gynecologists and otolaryngology surgeons' attitudes towards vaccination in themselves and their patients.

Authors:  Claire Stanley; Michael Secter; Sarah Chauvin; Amanda Selk
Journal:  Papillomavirus Res       Date:  2018-03-07

6.  Pricing of HPV vaccines in European tender-based settings.

Authors:  Venetia Qendri; Johannes A Bogaards; Johannes Berkhof
Journal:  Eur J Health Econ       Date:  2018-07-26

7.  Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey.

Authors:  Gilla K Shapiro; Samara Perez; Anila Naz; Ovidiu Tatar; Juliet R Guichon; Rhonda Amsel; Gregory D Zimet; Zeev Rosberger
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

8.  Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK.

Authors:  Gilla K Shapiro; Didi Surian; Adam G Dunn; Ryan Perry; Margaret Kelaher
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

9.  HPV vaccination intention among male clients of a large STI outpatient clinic in Amsterdam, the Netherlands.

Authors:  E Marra; C J Alberts; G D Zimet; T G W M Paulussen; T Heijman; A A Hogewoning; G J B Sonder; J S Fennema; H J C de Vries; M F Schim van der Loeff
Journal:  Papillomavirus Res       Date:  2016-11-05

10.  Knowledge and Attitudes of General Practitioners and Sexual Health Care Professionals Regarding Human Papillomavirus Vaccination for Young Men Who Have Sex with Men.

Authors:  Samuel W D Merriel; Carrie Flannagan; Joanna M Kesten; Gilla K Shapiro; Tom Nadarzynski; Gillian Prue
Journal:  Int J Environ Res Public Health       Date:  2018-01-18       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.